"Retina Associates of Cleveland is the largest group practice of ophthalmologists in Ohio who specialize in the medical and surgical treatment of diseases of the retina, including age-related macular degeneration (AMD), diabetic retinopathy, flashes and floaters, and retinal detachment. We have multiple convenient neighborhood offices across NE Ohio to serve you. Calling 1-800-4-RETINA will connect you with our Beachwood office to help set up an appointment in a location near you. For information about our doctors, our practice, our clinical studies, or for educational information about retina diseases, please visit our website."

During the past decade, Retina-Associates of Cleveland, Inc conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 21 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 14 clinical trials were completed. i.e. 93.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina-Associates of Cleveland, Inc" #1 sponsor was "Jaeb Center for Health Research" with 16 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Neurotech Pharmaceuticals" with 6 trials sponsored, "Genentech, Inc." with 4 trials sponsored and "Kodiak Sciences Inc" with 4 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina-Associates of Cleveland, Inc" #1 collaborator was "National Eye Institute (NEI)" with 18 trials as a collaborator, "Genentech, Inc." with 5 trials as a collaborator, "National Institutes of Health (NIH)" with 5 trials as a collaborator, "Regeneron Pharmaceuticals" with 4 trials as a collaborator and "Allergan" with 3 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Retina-Associates of Cleveland, Inc" are "Diabetic Macular Edema" (15 trials), "Geographic Atrophy" (10 trials), "Diabetic Retinopathy" (8 trials), "Macular Degeneration" (5 trials) and "Macular Telangiectasia Type 2" (5 trials). Many other conditions were trialed in "Retina-Associates of Cleveland, Inc" in a lesser frequency.

Most popular intervention types in "Retina-Associates of Cleveland, Inc" are "Drug" (49 trials), "Other" (17 trials), "Procedure" (14 trials), "Biological" (4 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (11 trials), "Aflibercept" (6 trials), "Placebo" (6 trials), "Faricimab" (5 trials) and "KSI-301" (4 trials). Other intervention names were less common.

The vast majority of trials in "Retina-Associates of Cleveland, Inc" are 65 trials for "All" genders.

Currently, there are NaN active trials in "Retina-Associates of Cleveland, Inc". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Retina-Associates of Cleveland, Inc, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Retina-Associates of Cleveland, Inc, 2 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".